Skip to content

Prognosis of metastatic lung cancer in the real-world setting. : A multi-center prospective cohort study (REAL-WIND2 study)(WJOG17423L)

Prognosis of metastatic lung cancer in the real-world setting. : A multi-center prospective cohort study (REAL-WIND2 study)(WJOG17423L) - REAL-WIND2 study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000053467
Enrollment
6000
Registered
2024-06-01
Start date
2024-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

None listed

Sponsors

West Japan Oncology Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with clinical stage IV lung cancer according to the TNM classification after January 1, 2024 2) Cases in which consent was obtained using the consent document for this study

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Overall survival, prediction accuracy of survival

Countries

Japan

Contacts

Public ContactNaoki Ishizuka

West Japan Oncology Group WJOG datacenter

datacenter@wjog.jp06-6633-7400

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026